Literature DB >> 11937029

The protein kinase C pathway is required for viability in quiescence in Saccharomyces cerevisiae.

Sue Ann Krause1, Joseph V Gray.   

Abstract

Protein kinase C, encoded by PKC1, regulates construction of the cell surface in vegetatively growing yeast cells. Pkc1 in part acts by regulating Mpk1, a MAP kinase. Mutants lacking Bck1, a component of the MAP kinase branch of the pathway, fail to respond normally to nitrogen starvation, which causes entry into quiescence. Given that the Tor1 and Tor2 proteins are key inhibitors of entry into quiescence, the Pkc1 pathway may regulate these proteins. We find that pkc1Delta and mpk1Delta mutants rapidly die by cell lysis upon carbon or nitrogen starvation. The Pkc1 pathway does not regulate the TOR proteins: transcriptional changes dependent on inhibition of the TORs occur normally in pkc1Delta and mpk1Delta mutants when starved for nitrogen; pkc1Delta and mpk1Delta mutants die rapidly upon treatment with rapamycin, an inhibitor of the TORs. We find that Mpk1 is transiently activated by rapamycin treatment via a novel mechanism. Finally, we find that rapamycin treatment or nitrogen starvation induces resistance to the cell wall-digesting enzyme zymolyase by a Pkc1-dependent mechanism. Thus, the Pkc1 pathway is not a nutrient sensor but acts downstream of TOR inhibition to maintain cell integrity in quiescence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11937029     DOI: 10.1016/s0960-9822(02)00760-1

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  34 in total

Review 1.  Transcriptional regulation in yeast during diauxic shift and stationary phase.

Authors:  Luciano Galdieri; Swati Mehrotra; Sean Yu; Ales Vancura
Journal:  OMICS       Date:  2010-09-23

2.  Influence of genotype and nutrition on survival and metabolism of starving yeast.

Authors:  Viktor M Boer; Sasan Amini; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-02       Impact factor: 11.205

3.  The TOR complex 1 is a direct target of Rho1 GTPase.

Authors:  Gonghong Yan; Yumei Lai; Yu Jiang
Journal:  Mol Cell       Date:  2012-03-22       Impact factor: 17.970

4.  Recovery from rapamycin: drug-insensitive activity of yeast target of rapamycin complex 1 (TORC1) supports residual proliferation that dilutes rapamycin among progeny cells.

Authors:  Stephanie K Evans; Karl E V Burgess; Joseph V Gray
Journal:  J Biol Chem       Date:  2014-08-07       Impact factor: 5.157

5.  Mtl1 is required to activate general stress response through Tor1 and Ras2 inhibition under conditions of glucose starvation and oxidative stress.

Authors:  Mima Ivanova Petkova; Nuria Pujol-Carrion; Javier Arroyo; Jesús García-Cantalejo; Maria Angeles de la Torre-Ruiz
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

6.  Sol-Generating Chemical Vapor into Liquid (SG-CViL) Deposition- A Facile Method for Encapsulation of Diverse Cell Types in Silica Matrices.

Authors:  Robert Johnston; Snezna Rogelj; Jason C Harper; Michaelann Tartis
Journal:  J Mater Chem B       Date:  2015-02-14       Impact factor: 6.331

7.  Cohesin dysfunction results in cell wall defects in budding yeast.

Authors:  Deepash Kothiwal; Swagathnath Gopinath; Shikha Laloraya
Journal:  Genetics       Date:  2021-03-03       Impact factor: 4.562

8.  The rapamycin-sensitive phosphoproteome reveals that TOR controls protein kinase A toward some but not all substrates.

Authors:  Alexandre Soulard; Alessio Cremonesi; Suzette Moes; Frédéric Schütz; Paul Jenö; Michael N Hall
Journal:  Mol Biol Cell       Date:  2010-08-11       Impact factor: 4.138

9.  The functional relationships underlying a synthetic genetic network.

Authors:  Sue A Krause; Joseph V Gray
Journal:  Commun Integr Biol       Date:  2009

10.  TOR under stress: targeting TORC1 by Rho1 GTPase.

Authors:  Gonghong Yan; Yumei Lai; Yu Jiang
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.